TABLE 2.
Tumor characteristics of patients without prior treatment
| Total n (%) | COVID period group (%) | Pre‐COVID period group (%) | p‐value | |
|---|---|---|---|---|
| Total number | 231 | 103 | 128 | |
| Median duration of symptoms prior to first visit, weeks (range) | 12 (1–104) | 12 (1–104) | 12 (4–52) | 0.391 |
| Median duration from diagnosis to first visit, days (range) | 23 (0–135) | 20 (0–133) | 25 (0–135) | 0.133 |
| Median duration from first visit to presentation at multidisciplinary tumor conference, days (range) | 2 (0–28) | 2 (0–13) | 2 (0–28) | 0.507 |
| Tumor (T) classification (n = 185) | ||||
| Tx | 5 (2.7) | 4 (5.1) | 1 (0.9) | 0.111 a |
| T0 | 1 (0.5) | 1 (1.3) | 0 (0.0) | |
| T1 | 55 (29.7) | 16 (20.5) | 39 (36.4) | |
| T2 | 58 (31.4) | 26 (33.3) | 32 (29.9) | |
| T3 | 38 (20.5) | 18 (23.1) | 20 (18.7) | |
| T4 | 28 (15.1) | 13 (16.7) | 15 (14.0) | |
| Nodal (N) classification (n = 185) | ||||
| N0 | 99 (53.5) | 42 (53.8) | 57 (53.3) | 0.656 a |
| N1 | 32 (27.6) | 23 (29.5) | 28 (26.2) | |
| N2 | 32 (17.3) | 11 (14.1) | 21 (19.6) | |
| N3 | 3 (1.6) | 2 (2.6) | 1 (0.9) | |
| Metastasis (M) classification (n = 185) | ||||
| Mx | 10 (5.4) | 6 (7.7) | 4 (3.7) | 0.360 a |
| M0 | 168 (90.8) | 68 (87.2) | 100 (93.5) | |
| M1 | 7 (3.8) | 4 (5.1) | 3 (2.8) | |
| AJCC 8th edition group stage (n = 179) | ||||
| 1 | 66 (36.9) | 25 (33.8) | 41 (39.0) | 0.782 |
| 2 | 43 (24.0) | 20 (27.0) | 23 (21.9) | |
| 3 | 34 (19.0) | 13 (17.6) | 21 (20.0) | |
| 4 | 36 (10.1) | 16 (21.6) | 20 (19.0) | |
| Median size of primary tumor, longest dimension, cm (range) | 2.5 (0.3–10.2) | 2.9 (0.5–10.2) | 2.2 (0.3–8.2) | 0.042 |
| Median size of largest nodal metastasis, longest dimension, cm (range) | 2.4 (0.8–7.0) | 2.6 (0.8–7.0) | 2.0 (0.8–4.8) | 0.145 |
Note: The italic n indicates number.
a
Fisher's exact test.